loader
Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Ombitasvir / paritaprevir / ritonavir.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5AbbVie Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
BioProcess International
Not Confirmed

Technivie

Brand Name : TECHNIVIE

Patent Number : 2737601

Filing Date : 2010-06-10

Strength per Unit : 12.5 mg / 75 mg / 50 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-06-10

Date Granted : 2014-10-21

Abbvie Company Banner

02

arrow
BioProcess International
Not Confirmed

Technivie

Brand Name : TECHNIVIE

Patent Number : 2510949

Filing Date : 1999-07-19

Strength per Unit : 12.5 mg / 75 mg / 50 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2019-07-19

Date Granted : 2009-11-17

Abbvie Company Banner

03

arrow
BioProcess International
Not Confirmed

Technivie

Brand Name : TECHNIVIE

Patent Number : 2337846

Filing Date : 1999-07-19

Strength per Unit : 12.5 mg / 75 mg / 50 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2019-07-19

Date Granted : 2006-02-21

Abbvie Company Banner

04

arrow
BioProcess International
Not Confirmed

Technivie

Brand Name : TECHNIVIE

Patent Number : 2224738

Filing Date : 1996-06-28

Strength per Unit : 12.5 mg / 75 mg / 50 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2016-06-28

Date Granted : 2002-08-27

Abbvie Company Banner

05

arrow
BioProcess International
Not Confirmed

Technivie

Brand Name : TECHNIVIE

Patent Number : 2736895

Filing Date : 2009-09-10

Strength per Unit : 12.5 mg / 75 mg / 50 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-09-10

Date Granted : 2016-02-09

Abbvie Company Banner